NO963031D0 - Metalloproteinaseinhibitorer - Google Patents
MetalloproteinaseinhibitorerInfo
- Publication number
- NO963031D0 NO963031D0 NO963031A NO963031A NO963031D0 NO 963031 D0 NO963031 D0 NO 963031D0 NO 963031 A NO963031 A NO 963031A NO 963031 A NO963031 A NO 963031A NO 963031 D0 NO963031 D0 NO 963031D0
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- group
- phenyl
- soch2ph
- cyclohexylmethylsulphanyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9401416A GB9401416D0 (en) | 1994-01-22 | 1994-01-22 | Metalloproteinase inhibitors |
GB9413566A GB9413566D0 (en) | 1994-07-06 | 1994-07-06 | Metalloproteinase inhibitors |
PCT/GB1995/000121 WO1995019961A1 (en) | 1994-01-22 | 1995-01-23 | Metalloproteinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO963031D0 true NO963031D0 (no) | 1996-07-19 |
NO963031L NO963031L (no) | 1996-09-20 |
Family
ID=26304212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO963031A NO963031L (no) | 1994-01-22 | 1996-07-19 | Metalloproteinaseinhibitorer |
Country Status (16)
Country | Link |
---|---|
US (2) | US5902791A (no) |
EP (2) | EP0740655B1 (no) |
JP (1) | JP3827324B2 (no) |
KR (1) | KR970700652A (no) |
AT (1) | ATE185798T1 (no) |
AU (1) | AU678884B2 (no) |
CA (1) | CA2181709A1 (no) |
DE (2) | DE69512891T2 (no) |
DK (1) | DK0740655T3 (no) |
ES (1) | ES2139183T3 (no) |
FI (1) | FI962905A (no) |
GR (1) | GR3032337T3 (no) |
HU (1) | HUT74511A (no) |
NO (1) | NO963031L (no) |
NZ (1) | NZ278632A (no) |
WO (1) | WO1995019961A1 (no) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
GB9401129D0 (en) * | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
GB9414157D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Medical use |
GB9601042D0 (en) * | 1996-01-17 | 1996-03-20 | Smithkline Beecham Plc | Medical use |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
AU2986295A (en) * | 1995-07-19 | 1997-02-18 | British Biotech Pharmaceuticals Limited | N-(amino acid) substituted succinic acid amide derivatives as metalloproteinase inhibitors |
AU7335496A (en) * | 1995-10-23 | 1997-05-15 | Sankyo Company Limited | Hyroxamic acid derivatives |
NZ322553A (en) | 1995-11-23 | 1998-12-23 | British Biotech Pharm | Metalloproteinase inhibitors |
US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
DK0874830T3 (da) * | 1995-12-08 | 2003-04-22 | Agouron Pharma | Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf |
AU1812197A (en) * | 1996-03-01 | 1997-09-16 | Sankyo Company Limited | Hydroxamic acid derivatives |
HRP970244B1 (en) * | 1996-05-15 | 2005-06-30 | Bayer Corporation | Inhibition of matrix metalloproteases by 2-substit |
US5925637A (en) | 1997-05-15 | 1999-07-20 | Bayer Corporation | Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
US5932577A (en) * | 1996-05-15 | 1999-08-03 | Bayer Corporation | Substituted oxobutyric acids as matrix metalloprotease inhibitors |
TNSN97085A1 (fr) * | 1996-05-15 | 2005-03-15 | Bayer Corp | Substitution oxybuterique des acides comme inhibiteurs de la matrice metalloprotease |
GB9616643D0 (en) * | 1996-08-08 | 1996-09-25 | Chiroscience Ltd | Compounds |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
CZ298048B6 (cs) | 1996-09-10 | 2007-06-06 | British Biotech Pharmaceuticals Limited | Farmaceutický prostredek a deriváty kyseliny hydroxamové |
US6500983B2 (en) * | 1996-10-02 | 2002-12-31 | Novartis Ag | Hydroxamic acid derivatives |
KR20000048811A (ko) * | 1996-10-02 | 2000-07-25 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 히드록삼산 유도체 |
US6174915B1 (en) | 1997-03-25 | 2001-01-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6008243A (en) * | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
ZA9818B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
ZA98376B (en) * | 1997-01-23 | 1998-07-23 | Hoffmann La Roche | Sulfamide-metalloprotease inhibitors |
US6376506B1 (en) | 1997-01-23 | 2002-04-23 | Syntex (U.S.A.) Llc | Sulfamide-metalloprotease inhibitors |
US6172057B1 (en) | 1997-02-27 | 2001-01-09 | American Cyanamid Company | N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
US6197791B1 (en) | 1997-02-27 | 2001-03-06 | American Cyanamid Company | N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
EP0971895A1 (en) | 1997-03-28 | 2000-01-19 | AstraZeneca AB | Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
GB9707333D0 (en) | 1997-04-11 | 1997-05-28 | British Biotech Pharm | Metalloproteinase inhibitors |
AUPO721997A0 (en) * | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
WO1999007679A1 (en) * | 1997-08-08 | 1999-02-18 | Chiroscience Limited | Peptidyl compounds having mmp and tnf inhibitory activity |
US6211209B1 (en) * | 1997-08-08 | 2001-04-03 | Warner-Lambert Company | Method of inhibiting connective tissue degradation |
US6130220A (en) * | 1997-10-16 | 2000-10-10 | Syntex (Usa) Inc. | Sulfamide-metalloprotease inhibitors |
CN1284942A (zh) | 1998-01-09 | 2001-02-21 | 辉瑞大药厂 | 基质金属蛋白酶抑制剂 |
PL342548A1 (en) * | 1998-02-19 | 2001-06-18 | American Cyanamid Co | N-hydroxy-2-(alkyl-, aryl- or heteroarylsulphanyl-, sulphinyl- or sulphonyl)-3-substituted alkyl-, aryl- or heteroarylamides as inhibitors of matrix metaloproteinases |
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
FR2780402B1 (fr) * | 1998-06-30 | 2001-04-27 | Adir | Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
US6696456B1 (en) | 1999-10-14 | 2004-02-24 | The Procter & Gamble Company | Beta disubstituted metalloprotease inhibitors |
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
EP1265887A2 (en) * | 2000-03-21 | 2002-12-18 | The Procter & Gamble Company | Carbocyclic side chain containing metalloprotease inhibitors |
NZ520657A (en) * | 2000-03-21 | 2004-11-26 | Procter & Gamble | Heterocyclic side chain containing, N-substituted metalloprotease inhibitors |
JP2003528082A (ja) * | 2000-03-21 | 2003-09-24 | ザ プロクター アンド ギャンブル カンパニー | ニフッ化酪酸メタロプロテアーゼ阻害物質 |
AR028606A1 (es) * | 2000-05-24 | 2003-05-14 | Smithkline Beecham Corp | Nuevos inhibidores de mmp-2/mmp-9 |
DK1243262T3 (da) * | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter |
JP2006516252A (ja) * | 2002-12-27 | 2006-06-29 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | コラーゲンおよびmmpiを用いる組成物および方法 |
AU2003300076C1 (en) | 2002-12-30 | 2010-03-04 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
EP3052475B1 (en) * | 2013-10-01 | 2018-08-08 | Olatec Therapeutics LLC | Pharmaceutical use of 3-benzylsulfonylpropionitrile |
US9999610B2 (en) | 2013-10-01 | 2018-06-19 | Olatec Therapeutics Llc | Pharmaceutical use of 3-benzylsulfonylpropionitrile |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL122359C (no) * | 1964-03-06 | |||
DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
US5525629A (en) * | 1992-04-07 | 1996-06-11 | British Bio-Technology Limited | Inhibition of cytokine production |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
US5310121A (en) * | 1992-07-24 | 1994-05-10 | Consilium Bulk Babcock Atlanta, Inc. | Cold weather bulk stacker/reclaimer apparatus and method |
US5714491A (en) * | 1993-04-27 | 1998-02-03 | Celltech Therapeutics Limited | Peptidyl derivatives as metalloproteinase inhibitors |
GB9308695D0 (en) * | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
GB9401129D0 (en) * | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
-
1995
- 1995-01-23 CA CA002181709A patent/CA2181709A1/en not_active Abandoned
- 1995-01-23 AU AU14603/95A patent/AU678884B2/en not_active Ceased
- 1995-01-23 US US08/676,359 patent/US5902791A/en not_active Expired - Fee Related
- 1995-01-23 NZ NZ278632A patent/NZ278632A/en unknown
- 1995-01-23 KR KR1019960703943A patent/KR970700652A/ko not_active Application Discontinuation
- 1995-01-23 HU HU9601987A patent/HUT74511A/hu unknown
- 1995-01-23 DE DE69512891T patent/DE69512891T2/de not_active Expired - Fee Related
- 1995-01-23 DK DK95906403T patent/DK0740655T3/da active
- 1995-01-23 AT AT95906403T patent/ATE185798T1/de not_active IP Right Cessation
- 1995-01-23 DE DE69529100T patent/DE69529100T2/de not_active Expired - Fee Related
- 1995-01-23 EP EP95906403A patent/EP0740655B1/en not_active Expired - Lifetime
- 1995-01-23 WO PCT/GB1995/000121 patent/WO1995019961A1/en active IP Right Grant
- 1995-01-23 ES ES95906403T patent/ES2139183T3/es not_active Expired - Lifetime
- 1995-01-23 EP EP98121251A patent/EP0905126B1/en not_active Expired - Lifetime
- 1995-01-23 JP JP51942495A patent/JP3827324B2/ja not_active Expired - Fee Related
-
1996
- 1996-07-19 NO NO963031A patent/NO963031L/no unknown
- 1996-07-19 FI FI962905A patent/FI962905A/fi unknown
-
1998
- 1998-12-23 US US09/219,704 patent/US6017889A/en not_active Expired - Fee Related
-
2000
- 2000-01-12 GR GR20000400035T patent/GR3032337T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2181709A1 (en) | 1995-07-27 |
EP0740655A1 (en) | 1996-11-06 |
DE69529100T2 (de) | 2003-07-17 |
NZ278632A (en) | 1998-04-27 |
HU9601987D0 (en) | 1996-09-30 |
HUT74511A (en) | 1997-01-28 |
AU678884B2 (en) | 1997-06-12 |
JPH09508362A (ja) | 1997-08-26 |
AU1460395A (en) | 1995-08-08 |
US6017889A (en) | 2000-01-25 |
EP0905126B1 (en) | 2002-12-04 |
FI962905A0 (fi) | 1996-07-19 |
DE69529100D1 (de) | 2003-01-16 |
ATE185798T1 (de) | 1999-11-15 |
NO963031L (no) | 1996-09-20 |
EP0740655B1 (en) | 1999-10-20 |
KR970700652A (ko) | 1997-02-12 |
FI962905A (fi) | 1996-07-19 |
GR3032337T3 (en) | 2000-04-27 |
JP3827324B2 (ja) | 2006-09-27 |
DE69512891D1 (en) | 1999-11-25 |
US5902791A (en) | 1999-05-11 |
ES2139183T3 (es) | 2000-02-01 |
WO1995019961A1 (en) | 1995-07-27 |
DE69512891T2 (de) | 2000-02-24 |
DK0740655T3 (da) | 2000-03-27 |
EP0905126A1 (en) | 1999-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69529100D1 (de) | Metalloproteinaseinhibitoren | |
AU1309988A (en) | Pyrazole derivative and herbicide containing it | |
BRPI0506906A (pt) | composição farmacêutica sólida estável, processos para a estabilização de um sal, e para a preparação de um sal cristalino, e, sal cristalino | |
JO2668B1 (en) | Isoczazolins for controlling invertebrate insects | |
ES2191484T3 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
ES467961A1 (es) | Procedimiento para preparar derivados de calconas | |
NO974844L (no) | Benzimidazolforbindelser, farmasöytiske sammensetninger som inneholder forbindelsene og deres anvendelser | |
DK534083A (da) | 1-carbonyl-1-phenoxyphenyl-2-azolyl-ethanol-derivater, syreadditionssalte, kvaternaere azoliumsalte og metalkomplekser deraf samt deres fremstilling og anvendelse som mikrobicider og plantevaekstregulatorer | |
DE3369315D1 (en) | Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity | |
DE69531350D1 (de) | Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze | |
NO941080D0 (no) | Fluorinerte 17 ater | |
CA2063938A1 (en) | Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis | |
DE69833797D1 (de) | Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen | |
AU2001282282A1 (en) | Use of percarbamic acids and diacyl percarbamates and precursors therefor | |
SE7710395L (sv) | Bekempningsmedel mot skadegorare | |
NO992981D0 (no) | 16-en-vitamin D derivater | |
NO972916L (no) | Dimerkapto-1,3-ditiola-2-on- eller -tionmaleimider, blandinger inneholdende dem og deres anvendelse som antimikrobielle og marine antibegroingsmidler | |
WO2003011859A3 (en) | Oxazolidinone derivatives as antibacterial agents | |
TR200401511T4 (tr) | Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri. | |
BR9300387A (pt) | Processo para reduzir impurezas de protoanemonina em solucoes aquosas de monomeros | |
DK289685A (da) | Substituerede 5-acylamino-1-phenylpyrazoler, deres fremstilling oganvendelse som herbicide midler | |
ATE71368T1 (de) | N-aryltetrahydrophthalimidderivate und deren vorprodukte. | |
KR900018033A (ko) | 나프탈렌프로피온산 염 | |
DK289587A (da) | Agrokemisk mikrobicid | |
ES2188278T3 (es) | Derivados de 3-(heterociclil)-benzoilpirazol. |